C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/4709 (2006.01) A61K 31/496 (2006.01) A61P 35/00 (2006.01) C07D 471/04 (2006.01) C07D 491/056 (2006.01) C07D 495/04 (2006.01) C07D 497/04 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2387840
The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
L'invention concerne des composés qui inhibent, régulent et/ou modulent la transduction de signal de tyrosine kinase, ainsi que des compositions renfermant ces composés, et des procédés d'utilisation de ces derniers pour traiter, chez le mammifère, les maladies et conditions dépendant de la tyrosine kinase, telles que l'angiogénèse, le cancer, la croissance tumorale, l'athérosclérose, la dégénération maculaire liée au vieillissement, la rétinopathie diabétique et les maladies inflammatoires, entre autres.
Fraley Mark E.
Hambaugh Scott R.
Hungate Randall W.
Merck & Co. Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1779584